| Name | Title | Contact Details |
|---|
Inovia Capital is a venture firm that partners up with audacious founders ready to build enduring global technology companies. We are known to roll up our sleeves and serve founders with dedicated, long-term mentorship, a global talent network and strategic support for global scale. Inovia Capital manages over US$1.5B across early and growth-stage funds and holds offices in Montreal, Toronto, Calgary, San Francisco and London.
Chapman Investments Ext is a Montgomery, AL-based company in the Financial Services sector.
Coalesce Capital is a private equity firm that partners with management teams to build long-term value around differentiated businesses. We are entirely focused on human capital-driven and technology-enabled business services companies and our investment philosophy centers around our conviction that people are the most important ingredient of success. Coalesce teams with middle market business services companies to develop and execute long-term strategic plans focused on accelerating both organic and inorganic growth, leveraging our extensive network of functional and industry advisors to lend specific expertise. The word coalesce reflects our core values and approach: we partner with management teams to come together to create shared success and the platforms of tomorrow.
Tarbell Financial Corporation is a Santa Ana, CA-based company in the Financial Services sector.
Harris and Harris Group, Inc. builds transformative companies from disruptive science. We leverage our core scientific expertise to be FIRST in identifying new technology trends, in accessing high quality science and intellectual property, in building management teams and in executing on early-stage business growth. Our PROVEN team has the unique ability to identify and diligence the network of discoveries that come from understanding science at the intersection of different scientific disciplines, with biology as a focus. This places us at the center of the discoveries impacting some of the most important growth sectors of the economy, permitting us to build TRANSFORMATIVE companies. BIOLOGY+ is our distinctive approach. We define BIOLOGY+ as investments in interdisciplinary life science companies where biology innovation is intersecting with innovations in areas such as electronics, physics, materials science, chemistry, information technology, engineering and mathematics. We focus on this intersection because we believe interdisciplinary innovation will be required in order to address many of the life science challenges of the future.